Last 12 months
Inside the activity.
1 purchase rows · 60 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 1 | 6 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 10 |
| Jul 2026 | 0 | 12 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2023 Filed Apr 14, 2023 20:33 UTC |
Fromkin Andrew J.Director
|
GrantStock Option (right to buy) · Derivative | 16,260 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001764013-23-000045 · wf-form4_168150437013871.xml · derivative · entry 2 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,260 Underlying: Common Stock · 16,260 shares Expires 2033-04-12 F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:33 UTC |
Fromkin Andrew J.Director
|
GrantCommon Stock | 12,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-23-000045 · wf-form4_168150437013871.xml · nonDerivative · entry 1 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,008 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:29 UTC |
Torti FrankDirector
|
GrantStock Option (right to buy) · Derivative | 158,292 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001764013-23-000043 · wf-form4_168150413461709.xml · derivative · entry 2 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,292 Underlying: Common Stock · 158,292 shares Expires 2033-04-12 F3 · derivative.exercise_date: Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:29 UTC |
Torti FrankDirector
|
GrantCommon Stock | 121,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-23-000043 · wf-form4_168150413461709.xml · nonDerivative · entry 1 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 515,274 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:26 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
GrantStock Option (right to buy) · Derivative | 130,081 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001764013-23-000042 · wf-form4_168150398782671.xml · derivative · entry 2 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,081 Underlying: Common Stock · 130,081 shares Expires 2033-04-12 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:26 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
GrantCommon Stock | 100,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-23-000042 · wf-form4_168150398782671.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,607 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:24 UTC |
Levine Mark S.Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 113,821 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001764013-23-000041 · wf-form4_168150383601971.xml · derivative · entry 2 Levine Mark S. · CIK 0001617236 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,821 Underlying: Common Stock · 113,821 shares Expires 2033-04-12 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:24 UTC |
Levine Mark S.Chief Legal Officer
|
GrantCommon Stock | 87,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-23-000041 · wf-form4_168150383601971.xml · nonDerivative · entry 1 Levine Mark S. · CIK 0001617236 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,324 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:22 UTC |
Barnett Eva ReneeChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 113,821 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001764013-23-000040 · wf-form4_168150372133037.xml · derivative · entry 2 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,821 Underlying: Common Stock · 113,821 shares Expires 2033-04-12 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:22 UTC |
Barnett Eva ReneeChief Financial Officer
|
GrantCommon Stock | 87,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-23-000040 · wf-form4_168150372133037.xml · nonDerivative · entry 1 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,011 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:14 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 316,585 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001764013-23-000038 · wf-form4_168150324964962.xml · derivative · entry 2 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,585 Underlying: Common Stock · 316,585 shares Expires 2033-04-12 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 12, 2024 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 20:14 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
GrantCommon Stock | 243,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-23-000038 · wf-form4_168150324964962.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,237,764 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on April 12, 2024 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 07:24 UTC |
Macias William L.Chief Medical Officer
|
SaleCommon Stock | 537 | $18.24 | $9,794.88 |
DisclosureSEC source: 0001764013-23-000024 · wf-form4_167542704698516.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,996 F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 1,167 of these RSUs vested on January 13, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| January 26, 2023 Filed Jan 27, 2023 12:20 UTC |
Levine Mark S.Chief Legal Officer
|
SaleCommon Stock | 10,156 | $18.51 | $187,987.56 |
DisclosureSEC source: 0001764013-23-000015 · wf-form4_167482200506238.xml · nonDerivative · entry 1 Levine Mark S. · CIK 0001617236 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,660 F1 · security: On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 35,750 of these RSUs vested on January 19, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 08:13 UTC |
Macias William L.Chief Medical Officer
|
SaleCommon Stock | 44,448 | $16.75 | $744,504.00 |
DisclosureSEC source: 0001764013-23-000006 · wf-form4_167361559332752.xml · nonDerivative · entry 2 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,533 F1 · security: On November 5, 2021, the holder was granted 112,108 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 9, 2021. These RSUs vested in their entirety on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs and do not represent a discretionary sale by the holder. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.30 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 08:13 UTC |
Macias William L.Chief Medical Officer
|
SaleCommon Stock | 120 | $15.11 | $1,813.20 |
DisclosureSEC source: 0001764013-23-000006 · wf-form4_167361559332752.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,981 F1 · security: On November 5, 2021, the holder was granted 112,108 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 9, 2021. These RSUs vested in their entirety on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.06 - $15.15 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 13:21 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 4,021 | $16.80 | $67,552.80 |
DisclosureSEC source: 0001764013-23-000012 · wf-form4_167361610100577.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,932 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,282 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.76 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 13:19 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 60,471 | $16.79 | $1,015,308.09 |
DisclosureSEC source: 0001764013-23-000010 · wf-form4_167361594694409.xml · nonDerivative · entry 2 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,419 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,407 of these RSUs vested on January 1, 2023. On August 3, 2021, the holder was granted 285,306 RSUs, as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 142,653 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligations due in connection with the vesting and settlement of these tranches of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.68 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 13:19 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 19 | $15.16 | $288.04 |
DisclosureSEC source: 0001764013-23-000010 · wf-form4_167361594694409.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,890 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,407 of these RSUs vested on January 1, 2023. On August 3, 2021, the holder was granted 285,306 RSUs, as previously reported on a Form 4 filed on August 4, 2021, of which the remaining 142,653 of these RSUs vested on January 1, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligations due in connection with the vesting and settlement of these tranches of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 13:16 UTC |
Barnett Eva ReneeChief Financial Officer
|
SaleCommon Stock | 4,499 | $16.75 | $75,358.25 |
DisclosureSEC source: 0001764013-23-000008 · wf-form4_167361579253284.xml · nonDerivative · entry 2 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,347 F1 · security: On October 15, 2021, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 18, 2021, of which 8,937 of these RSUs vested on January 4, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.31 - $16.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 11, 2023 Filed Jan 13, 2023 13:16 UTC |
Barnett Eva ReneeChief Financial Officer
|
SaleCommon Stock | 11 | $15.15 | $166.65 |
DisclosureSEC source: 0001764013-23-000008 · wf-form4_167361579253284.xml · nonDerivative · entry 1 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,846 F1 · security: On October 15, 2021, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 18, 2021, of which 8,937 of these RSUs vested on January 4, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 07:43 UTC |
Macias William L.Chief Medical Officer
|
SaleCommon Stock | 341 | $9.67 | $3,297.47 |
DisclosureSEC source: 0001764013-22-000134 · wf-form4_166669817084362.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,101 F1 · security: On June 11, 2021, the holder was granted 18,674 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021, of which 1,167 of these RSUs vested on October 13, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 12:59 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 928 | $9.18 | $8,519.04 |
DisclosureSEC source: 0001764013-22-000132 · wf-form4_166601156720429.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,909 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,406 of these RSUs vested on October 1, 2022 and the remainder of the RSUs vest in quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.18 - $9.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 12:57 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 2,793 | $9.18 | $25,639.74 |
DisclosureSEC source: 0001764013-22-000130 · wf-form4_166601145413186.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 997,953 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 8,281 of these RSUs vested on October 1, 2022 and the remainder of the RSUs vest in quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.18 - $9.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 20:20 UTC |
Barnett Eva ReneeChief Financial Officer
|
SaleCommon Stock | 12,500 | $9.44 | $118,000.00 |
DisclosureSEC source: 0001764013-22-000128 · wf-form4_166569241491854.xml · nonDerivative · entry 1 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,857 F1 · security: On October 15, 2021, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 18, 2021, of which 25% of these RSUs vested on October 4, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.16 - $9.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:32 UTC |
Roivant Sciences Ltd.10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 416,667 | $6.00 | $2,500,002.00 |
DisclosureSEC source: 0001140361-22-036652 · form4.xml · nonDerivative · entry 1 Roivant Sciences Ltd. · CIK 0001635088 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,805,331 Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:27 UTC |
Pande AtulDirector
|
PurchaseCommon Stock | 15,000 | $5.60 | $84,000.00 |
DisclosureSEC source: 0001764013-22-000126 · wf-form4_166491518472332.xml · nonDerivative · entry 1 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 20,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.59 - $5.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. F2 · ownership.nature: These shares are owned by a trust (the "Trust"). Certain members of the Reporting Person's immediate family are beneficiaries of the Trust. Read SEC document |
| September 29, 2022 Filed Sep 29, 2022 20:21 UTC |
Torti FrankDirector
|
PurchaseCommon Stock | 20,000 | $5.81 | $116,200.00 |
DisclosureSEC source: 0001764013-22-000120 · wf-form4_166448284375026.xml · nonDerivative · entry 1 Torti Frank · CIK 0001647805 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,358 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.68 - $5.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 21:09 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 535 | $4.67 | $2,498.45 |
DisclosureSEC source: 0001764013-22-000124 · wf-form4_166448577616322.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,837 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,135 of these RSUs vested on September 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 21:06 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 1,605 | $4.67 | $7,495.35 |
DisclosureSEC source: 0001764013-22-000122 · wf-form4_166448557706339.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,746 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,760 of these RSUs vested on September 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 11:36 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
SaleCommon Stock | 1,644 | $5.83 | $9,584.52 |
DisclosureSEC source: 0001764013-22-000112 · wf-form4_166203216200949.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002,351 F1 · security: On March 19, 2021, the holder was granted 132,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 2,761 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 11:33 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
SaleCommon Stock | 548 | $5.83 | $3,194.84 |
DisclosureSEC source: 0001764013-22-000111 · wf-form4_166203199206250.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,372 F1 · security: On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 1,136 of these RSUs vested on August 19, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:44 UTC |
MIGAUSKY GEORGE VDirector
|
GrantStock Option (right to buy) · Derivative | 31,668 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000093 · wf-form4_166094182912795.xml · derivative · entry 2 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,668 Underlying: Common Stock · 31,668 shares Expires 2032-08-17 F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:44 UTC |
MIGAUSKY GEORGE VDirector
|
GrantCommon Stock | 21,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000093 · wf-form4_166094182912795.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,985 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 16:56 UTC |
Macias William L.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 169,648 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000105 · wf-form4_166094256286794.xml · derivative · entry 2 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,648 Underlying: Common Stock · 169,648 shares Expires 2032-08-17 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 16:56 UTC |
Macias William L.Chief Medical Officer
|
GrantCommon Stock | 112,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000105 · wf-form4_166094256286794.xml · nonDerivative · entry 1 Macias William L. · CIK 0001864280 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,442 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:57 UTC |
Levine Mark S.Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 169,648 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000107 · wf-form4_166094266063739.xml · derivative · entry 2 Levine Mark S. · CIK 0001617236 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,648 Underlying: Common Stock · 169,648 shares Expires 2032-08-17 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:57 UTC |
Levine Mark S.Chief Legal Officer
|
GrantCommon Stock | 112,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000107 · wf-form4_166094266063739.xml · nonDerivative · entry 1 Levine Mark S. · CIK 0001617236 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,816 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:54 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
GrantStock Option (right to buy) · Derivative | 169,648 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000103 · wf-form4_166094246284096.xml · derivative · entry 2 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,648 Underlying: Common Stock · 169,648 shares Expires 2032-08-17 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:54 UTC |
Butchko Julia G.Chief Dev. & Tech. Officer
|
GrantCommon Stock | 112,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000103 · wf-form4_166094246284096.xml · nonDerivative · entry 1 Butchko Julia G. · CIK 0001796290 · Chief Dev. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,920 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:52 UTC |
Barnett Eva ReneeChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 169,648 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000101 · wf-form4_166094233293811.xml · derivative · entry 2 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,648 Underlying: Common Stock · 169,648 shares Expires 2032-08-17 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:52 UTC |
Barnett Eva ReneeChief Financial Officer
|
GrantCommon Stock | 112,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000101 · wf-form4_166094233293811.xml · nonDerivative · entry 1 Barnett Eva Renee · CIK 0001883766 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,357 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:50 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 678,592 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000099 · wf-form4_166094221021747.xml · derivative · entry 2 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678,592 Underlying: Common Stock · 678,592 shares Expires 2032-08-17 F3 · derivative.exercise_date: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on August 17, 2023 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:50 UTC |
Salzmann PeterDirector · Chief Executive Officer
|
GrantCommon Stock | 451,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000099 · wf-form4_166094221021747.xml · nonDerivative · entry 1 Salzmann Peter · CIK 0001796309 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,003,995 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest over four years, with 25% of the RSUs vesting on August 17, 2023 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:48 UTC |
Fromkin Andrew J.Director
|
GrantStock Option (right to buy) · Derivative | 31,668 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000097 · wf-form4_166094208760439.xml · derivative · entry 2 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,668 Underlying: Common Stock · 31,668 shares Expires 2032-08-17 F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:48 UTC |
Fromkin Andrew J.Director
|
GrantCommon Stock | 21,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000097 · wf-form4_166094208760439.xml · nonDerivative · entry 1 Fromkin Andrew J. · CIK 0001341896 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,485 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:46 UTC |
Pande AtulDirector
|
GrantStock Option (right to buy) · Derivative | 31,668 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000095 · wf-form4_166094195240810.xml · derivative · entry 2 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,668 Underlying: Common Stock · 31,668 shares Expires 2032-08-17 F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:46 UTC |
Pande AtulDirector
|
GrantCommon Stock | 21,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000095 · wf-form4_166094195240810.xml · nonDerivative · entry 1 Pande Atul · CIK 0001643071 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,985 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:41 UTC |
Hughes Douglas J.Director
|
GrantStock Option (right to buy) · Derivative | 31,668 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001764013-22-000091 · wf-form4_166094167115623.xml · derivative · entry 2 Hughes Douglas J. · CIK 0001710863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,668 Underlying: Common Stock · 31,668 shares Expires 2032-08-17 F3 · derivative.exercise_date: The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:41 UTC |
Hughes Douglas J.Director
|
GrantCommon Stock | 21,059 | $0.00 | $0.00 |
DisclosureSEC source: 0001764013-22-000091 · wf-form4_166094167115623.xml · nonDerivative · entry 1 Hughes Douglas J. · CIK 0001710863 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,232 F1 · security: Represents the number of shares underlying restricted stock units awards ("RSUs"). F2 · shares: The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.